Mead Johnson Reports Strong Fourth Quarter And Full Year Constant Dollar Sales Growth Of 7 Percent; Delivers Non-GAAP EPS Growth Of 10 Percent; Provides 2013 Guidance

Corporate and Other expenses decreased from lower IT and IPO-related separation costs, lower performance-based compensation expense and the elimination of duplicate costs from the overlap in shared services providers incurred in 2011 during the SAP implementation project. These factors were partially offset by higher pension settlement expense.

Outlook for 2013

“We expect to continue to deliver strong sales growth through 2013,” Mr. Golsby said. “We are initiating non-GAAP EPS guidance in the range of $3.22 to $3.30, up from the $3.08 per share we delivered in 2012. Annual constant dollar sales growth from ongoing operations are expected to be in the range of 7 percent to 8 percent and will be reduced by 1 percent as we exit several low margin non-core businesses. Therefore, key assumptions underlying non-GAAP guidance include an expected sales increase of 6 percent to 7 percent excluding the effect of foreign exchange. Improved gross margins will help fund continued increases in demand-generation investments. The 2013 non-GAAP effective tax rate is expected to be about 25 percent, slightly higher than the 24.3 percent reported in 2012, which included prior years' tax benefits.”

Conference Call Scheduled

Mead Johnson will host a conference call at 8:30 a.m. CST today, during which company executives will review fourth quarter and full year financial results and respond to questions from analysts and investors. The call will be broadcast over the Internet at meadjohnson.com. To listen to the call, visit the website at least 15 minutes before the call and click on the “Investors” tab. Security analysts and investors wishing to participate by telephone should call [phone], pass code: Mead Johnson. Callers outside of North America should call [phone] to be connected. A replay of the conference call will be available through midnight CST Thursday, February 7, 2013, by calling [phone] or outside of North America [phone], pass code: 63045245. The replay will also be available at meadjohnson.com.

Forward-Looking Statements

Certain statements in this news release are forward looking as defined in the Private Securities Litigation Reform Act of 1995. These statements, which are identified by words such as “expects,” “intends” and “believes,” involve certain risks, uncertainties and assumptions that may cause actual results to differ materially from expectations as of the date of this news release. These risks include, but are not limited to: (1) the ability to sustain brand strength, particularly the Enfa family of brands; (2) the effect on the company's reputation of real or perceived quality issues; (3) the adverse effect of commodity costs; (4) increased competition from branded, private label, store and economy-branded products; (5) the effect of an economic downturn on consumers' purchasing behavior and customers' ability to pay for product; (6) inventory reductions by customers; (7) the adverse effect of changes in foreign currency exchange rates; (8) the effect of changes in economic, political and social conditions in the markets where we operate; (9) legislative, regulatory or judicial action that may adversely affect the company's ability to advertise its products or maintain product margins; (10) the possibility of changes in the Women, Infant and Children (WIC) program, or participation in WIC; and (11) the ability to develop and market new, innovative products. For additional information on these and other factors, see the risk factors identified in the company's periodic reports, including the annual report on Form 10-K for 2011, quarterly reports on Form 10-Q and current reports on Form 8-K, filed with, or furnished to, the Securities and Exchange Commission, available upon request or at meadjohnson.com. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

About Mead Johnson

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company's mission is to nourish the world's children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company's “Enfa” family of brands, including Enfamil ^® infant formula, is the world's leading brand franchise in pediatric nutrition. For more information, go to meadjohnson.com.

MEAD JOHNSON NUTRITION COMPANY
CONSOLIDATED STATEMENTS OF EARNINGS
(Dollars and shares in millions, except per share data)
(UNAUDITED)
		Three Months Ended December 31,								Year Ended December 31,
		2012				2011				2012				2011
NET SALES		$	981.1			$	911.3			$	3,901.3			$	3,677.0
Cost of Products Sold		382.0				354.9				1,485.3				1,362.3
GROSS PROFIT		599.1				556.4				2,416.0				2,314.7
Expenses:
Selling, General and Administrative		235.6				237.3				877.8				926.8
Advertising and Promotion		139.5				128.7				552.8				501.7
Research and Development		27.8				28.1				95.4				92.5
Other Expenses		6.5				16.2				20.0				19.6
EARNINGS BEFORE INTEREST AND INCOME TAXES		189.7				146.1				870.0				774.1
Interest Expense		16.0				13.8				65.0				52.2
EARNINGS BEFORE INCOME TAXES		173.7				132.3				805.0				721.9
Provision for Income Taxes		41.4				43.0				192.6				202.9
NET EARNINGS		132.3				89.3				612.4				519.0
Less Net Earnings Attributable to Noncontrolling Interests		(1.9		)		3.7				7.9				10.5
NET EARNINGS ATTRIBUTABLE TO SHAREHOLDERS		$	134.2			$	85.6			$	604.5			$	508.5
Earnings per Share—Basic
Net Earnings Attributable to Shareholders		$	0.66			$	0.42			$	2.96			$	2.48
Earnings per Share—Diluted
Net Earnings Attributable to Shareholders		$	0.66			$	0.42			$	2.95			$	2.47
Weighted-average Shares		202.9				203.8				203.6				204.3
Dividends Declared per Share		$	0.30			$	0.26			$	1.20			$	1.04

MEAD JOHNSON NUTRITION COMPANY
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Dollars in millions)
(UNAUDITED)
		December 31,
		2012				2011
NET EARNINGS		$	612.4			$	519.0
OTHER COMPREHENSIVE INCOME/(LOSS)
Foreign Currency Translation Adjustments
Translation Adjustments		(8.4		)		(27.2		)
Tax Benefit/(Expense)		(13.0		)		4.7
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges for the Period		(12.7		)		5.8
Reclassification Adjustment for (Gains)/Losses Included in Net Earnings		0.8				2.9
Tax Benefit/(Expense)		3.5				(2.6		)
Pension and Other Post-Retirement Benefits
Deferred Gains on Pension and Other Post-Retirement Benefits		(58.5		)		(90.7		)
Reclassification Adjustment for (Gains)/Losses Included in Net Earnings		23.8				14.6
Tax Expense		10.6				24.1
OTHER COMPREHENSIVE INCOME/(LOSS)		(53.9		)		(68.4		)
COMPREHENSIVE INCOME		558.5				450.6
Less Comprehensive Income Attributable to Noncontrolling Interests		7.9				10.6
COMPREHENSIVE INCOME ATTRIBUTABLE TO SHAREHOLDERS		$	550.6			$	440.0

MEAD JOHNSON NUTRITION COMPANY
CONSOLIDATED BALANCE SHEETS
(Dollars and shares in millions, except per share data)
(UNAUDITED)
		December 31,
		2012				2011
ASSETS
CURRENT ASSETS:
Cash and Cash Equivalents		$	1,042.1			$	840.3
Receivables – net of allowances of $7.6 and $6.3, respectively		364.6				352.6
Inventories (1)		435.9				534.9
Deferred Income Taxes – net of valuation allowance		86.4				118.5
Income Taxes Receivable		26.0				3.3
Prepaid Expenses and Other Assets		60.0				40.1
Total Current Assets		2,015.0				1,889.7
Property, Plant, and Equipment – net		689.9				576.1
Goodwill		270.6				117.5
Other Intangible Assets – net		129.9				91.6
Deferred Income Taxes – net of valuation allowance		24.5				16.5
Other Assets		128.3				75.4
TOTAL		$	3,258.2			$	2,766.8
LIABILITIES AND EQUITY/(DEFICIT)
CURRENT LIABILITIES:
Short-term Borrowings		$	161.0			$	—
Accounts Payable		508.5				488.1
Dividends Payable		61.3				53.3
Note Payable		26.0				—
Accrued Expenses		220.4				229.0
Accrued Rebates and Returns		314.8				300.1
Deferred Income – current		36.1				47.0
Income Taxes – payable and deferred		41.8				82.6
Total Current Liabilities		1,369.9				1,200.1
Long-Term Debt		1,523.2				1,531.9
Deferred Income Taxes – noncurrent		15.9				5.2
Pension, Post-Retirement and Post Employment Liabilities		188.8				157.2
Other Liabilities		95.1				40.4
Total Liabilities		3,192.9				2,934.8
COMMITMENTS AND CONTINGENCIES
REDEEMABLE NONCONTROLLING INTEREST		36.3				—
EQUITY/(DEFICIT)
Shareholders’ Equity
Common Stock, $0.01 par value: 3,000 authorized, 206.0 and 205.1 issued, respectively		2.1				2.1
Additional Paid-in/(Distributed) Capital		(676.6		)		(728.4		)
Retained Earnings		1,124.8				770.0
Treasury Stock – at cost		(244.6		)		(89.7		)
Accumulated Other Comprehensive Loss		(187.0		)		(133.1		)
Total Shareholders’ Equity/(Deficit)		18.7				(179.1		)
Noncontrolling Interests		10.3				11.1
Total Equity/(Deficit)		29.0				(168.0		)
TOTAL		$	3,258.2			$	2,766.8

⁽¹⁾ For the year ended December 31, 2011, inventories included $77 million due to a higher level of advanced purchases for select dairy inputs

MEAD JOHNSON NUTRITION COMPANY
CONSOLIDATED STATEMENTS OF EQUITY/(DEFICIT) AND REDEEMABLE NONCONTROLLING INTEREST
(Dollars in millions)
(UNAUDITED)
						Additional												Accumulated												Redeemable
						Paid-in												Other				Non-				Total				Non-
		Common				(Distributed)				Retained				Treasury				Comprehensive				controlling				Equity/				controlling
		Stock				Capital				Earnings				Stock				Loss				Interests				(Deficit)				Interest
Balance as of December 31, 2010		$	2.0			$	(775.6	)		$	474.0			$	(3.2	)		$	(64.6	)		$	9.1			$	(358.3	)		$	—
Stock-based Compensation Awards (includes income tax benefits of $2.8)		0.1				47.2								(4.9		)										42.4
Treasury Stock Acquired														(81.6		)										(81.6		)
Distributions to Noncontrolling Interests																						(8.6		)		(8.6		)
Cash Dividends Declared										(212.5		)														(212.5		)
Net Earnings										508.5												10.5				519.0
Other Comprehensive Income (Loss)																		(68.5		)		0.1				(68.4		)
Balance as of December 31, 2011		$	2.1			$	(728.4	)		$	770.0			$	(89.7	)		$	(133.1	)		$	11.1			$	(168.0	)		$	—
Stock-based Compensation Awards (includes income tax benefits of $11.8)						51.8								(15.2		)										36.6
Treasury Stock Acquired														(139.7		)										(139.7		)
Acquisition																										—				30.2
Distributions to Noncontrolling Interests																						(7.6		)		(7.6		)
Cash Dividends Declared										(244.7		)														(244.7		)
Net Earnings										604.5												6.8				611.3				1.1
Redeemable Noncontrolling Interest Accretion										(5.0		)														(5.0		)		5.0
Other Comprehensive Income (Loss)																		(53.9		)		—				(53.9		)
Balance as of December 31, 2012		$	2.1			$	(676.6	)		$	1,124.8			$	(244.6	)		$	(187.0	)		$	10.3			$	29.0			$	36.3

MEAD JOHNSON NUTRITION COMPANY CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in millions)
(UNAUDITED)
		December 31,
		2012				2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Earnings		$	612.4			$	519.0
Adjustments to Reconcile Net Earnings to Net Cash Provided by Operating Activities:
Depreciation and Amortization		76.9				75.3
Stock-Based Compensation Expense		32.2				39.9
Deferred Income Tax		17.1				(33.3		)
Gain on Sale of Intangible Assets		(6.5		)		—
Exchange Loss from Devaluation		—				—
Other		1.8				2.3
Changes in Assets and Liabilities
Receivables		(8.5		)		(7.9		)
Inventories		109.8				(183.3		)
Accounts Payable		(30.9		)		114.7
Accrued Expenses, Rebates and Returns		(6.3		)		50.0
Income Taxes Payable		(62.2		)		53.2
Other Assets and Liabilities		(14.8		)		12.6
Pension and Other Post Retirement Benefits Contributions		(28.3		)		(9.7		)
Net Cash Provided by Operating Activities		692.7				632.8
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments for Capital Expenditures		(124.4		)		(109.5		)
Proceeds from Sale of Property, Plant and Equipment		1.5				1.6
Proceeds from Sale of Intangible Assets		6.5				—
Investment in Other Companies		(6.3		)		(4.7		)
Payment for Acquisition		(106.1		)		—
Net Cash Used in Investing Activities		(228.8		)		(112.6		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Short-term Borrowings		391.2				72.0
Repayments of Short-term Borrowings		(230.2		)		(73.2		)
Payment for Capital Lease Termination		—				—
Repayments of Notes Payable		(52.6		)		—
Payments of Dividends		(236.7		)		(205.7		)
Stock-based-compensation-related Proceeds and Excess Tax Benefits		23.3				4.5
Purchases of Treasury Stock		(154.9		)		(87.7		)
Proceeds from Termination of Interest Rate Swaps		—				23.5
Proceeds from Promissory Note		—				—
Distributions to Noncontrolling Interests		(7.6		)		(8.6		)
Net Cash Used in Financing Activities		(267.5		)		(275.2		)
Effects of Changes in Exchange Rates on Cash and Cash Equivalents		5.4				(0.3		)
NET INCREASE IN CASH AND CASH EQUIVALENTS		201.8				244.7
CASH AND CASH EQUIVALENTS:
Beginning of Period		840.3				595.6
End of Period		$	1,042.1			$	840.3

MEAD JOHNSON NUTRITION COMPANY
SUPPLEMENTAL FINANCIAL INFORMATION
(Dollars in millions)
(UNAUDITED)
The following chart has been restated for a segment reorganization implemented during the fourth quarter of 2012. See additional information on page 14 of this press release.
		Three Months Ended December 31,											% Change Due to
																			Foreign
Net Sales		2012				2011				% Change			Volume			Price			Exchange
Asia/Latin America		$	663.5			$	604.8			10	%		3	%		6	%		1	%
North America/Europe		317.6				306.5				4	%		(1	)%		5	%		—
Net Sales		$	981.1			$	911.3			8	%		2	%		5	%		1	%
Earnings Before Interest and Income Taxes		2012				2011				% Change
Asia/Latin America		$	187.4			$	179.7			4	%
North America/Europe		88.9				64.1				39	%
Corporate and Other		(86.6		)		(97.7		)		11	%
EBIT		$	189.7			$	146.1			30	%
		Year Ended December 31,											% Change Due to
																			Foreign
Net Sales		2012				2011				% Change			Volume			Price			Exchange
Asia/Latin America		$	2,719.5			$	2,447.2			11	%		5	%		7	%		(1	)%
North America/Europe		1,181.8				1,229.8				(4	)%		(7	)%		4	%		(1	)%
Net Sales		$	3,901.3			$	3,677.0			6	%		1	%		6	%		(1	)%
		Year Ended December 31,
Earnings Before Interest and Income Taxes		2012				2011				% Change
Asia/Latin America		$	901.3			$	811.6			11	%
North America/Europe		246.1				308.4				(20	)%
Corporate and Other		(277.4		)		(345.9		)		20	%
EBIT		$	870.0			$	774.1			12	%

Non-GAAP Financial Measures

This news release contains non-GAAP financial measures, including non-GAAP EBIT, earnings and earnings per share information. The items included in GAAP measures, but excluded for the purpose of determining non-GAAP EBIT, earnings and earnings per share, are IT separation and other costs (Specified Items). In addition, other items include the tax impact on Specified Items. Non-GAAP EBIT, earnings and earnings per share information adjusted for these items is an indication of the company's underlying operating results and intended to enhance an investor's overall understanding of the company's financial performance. In addition, this information is among the primary indicators the company uses as a basis for evaluating company performance, setting incentive compensation targets, and planning and forecasting of future periods. This information is not intended to be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. Tables that reconcile GAAP to non-GAAP disclosure follow:

MEAD JOHNSON NUTRITION COMPANY
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(Dollars in millions, except per share data)
(UNAUDITED)
FOR THE THREE MONTHS ENDED DECEMBER 31, 2012 AND 2011
									Earnings Before Interest									Net Earnings Attributable									Earnings per Common
									and Income Taxes									to Shareholders									Share - Diluted
									2012				2011					2012				2011					2012				2011
GAAP Results									$	189.7			$	146.1				$	134.2			$	85.6				$	0.66			$	0.42
Specified Items: (1)
IT and other separation costs (2)									7.9				13.5
Gain on sale of certain non-core intangible assets (3)									(1.0		)		—
Severance and other costs (3)									11.5				11.4
Legal, settlements and related costs (2,3)									(0.3		)		3.2
Specified Items before income taxes									18.1				28.1					18.1				28.1					0.09				0.14
Income tax impact on items above																		(5.6		)		(7.2		)			(0.03		)		(0.04		)
Non-GAAP Results									$	207.8			$	174.2				$	146.7			$	106.5				$	0.72			$	0.52

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2012 AND 2011
									Earnings Before Interest									Net Earnings Attributable									Earnings per Common
									and Income Taxes									to Shareholders									Share - Diluted
									2012				2011					2012				2011					2012				2011
GAAP Results									$	870.0			$	774.1				$	604.5			$	508.5				$	2.95			$	2.47
Specified Items: (1)
IT and other separation costs (2)									19.9				74.7
Gain on sale of certain non-core intangible assets (3)									(6.5		)		—
Severance and other costs (3)									21.1				11.6
Legal, settlements and related costs (2,3)									2.8				7.6
Specified Items before income taxes									37.3				93.9					37.3				93.9					0.18				0.46
Income tax impact on items above																		(11.7		)		(29.3		)			(0.05		)		(0.14		)
Non-GAAP Results									$	907.3			$	868.0				$	630.1			$	573.1				$	3.08			$	2.79

(1) All Specified Items are included in the Corporate and Other segment

(2) Included in Selling, General and Administrative expenses

(3) Included in Other Expenses/(Income)-net

Segment Reorganization

During the fourth quarter of 2012, the company implemented a change in its organizational structure involving the transfer of the Puerto Rican operations from the North America to the Latin America business. This change did not impact Europe or Asia and did not have a material impact on the assets of North America or Latin America. As a result of implementing this change in our operating structure, the company will report the results of operations under this new structure beginning with the fourth quarter of 2012. The following unaudited financial schedule provides information regarding net sales and earnings before interest and income taxes for 2010 and 2011, each of the four quarters of 2011, and each of the first three quarters of 2012 on the new reporting basis.

MEAD JOHNSON NUTRITION COMPANY
SUPPLEMENTAL FINANCIAL INFORMATION
(Dollars in millions)
(UNAUDITED)
			2012												2011																				2010
			1Q				2Q				3Q				1Q				2Q				3Q				4Q				Total Year				Total Year
Net Sales
Original Reportable Segment Structure:
	Asia/Latin America		$	701.3			$	695.2			$	639.9			$	576.9			$	611.6			$	636.1			$	598.6			$	2,423.2			$	1,927.1
	North America / Europe		285.3				317.1				281.4				322.9				320.4				297.8				312.7				1,253.8				1,214.5
Total			$	986.6			$	1,012.3			$	921.3			$	899.8			$	932.0			$	933.9			$	911.3			$	3,677.0			$	3,141.6
New Reportable Segment Structure:
	Asia/Latin America		$	707.3			$	702.0			$	646.7			$	582.5			$	617.1			$	642.8			$	604.8			$	2,447.2			$	1,951.0
	North America/Europe		279.3				310.3				274.6				317.3				314.9				291.1				306.5				1,229.8				1,190.6
Total			$	986.6			$	1,012.3			$	921.3			$	899.8			$	932.0			$	933.9			$	911.3			$	3,677.0			$	3,141.6
Earnings Before Interest and Taxes
Original Reportable Segment Structure:
	Asia/Latin America		$	279.0			$	237.5			$	190.7			$	216.8			$	209.8			$	198.4			$	177.9			$	802.9			$	646.1
	North America/Europe		33.7				74.6				55.6				92.9				86.4				71.9				65.9				317.1				357.7
	Corporate and Other		(63.9		)		(63.8		)		(63.1		)		(87.1		)		(92.5		)		(68.6		)		(97.7		)		(345.9		)		(320.9		)
Total			$	248.8			$	248.3			$	183.2			$	222.6			$	203.7			$	201.7			$	146.1			$	774.1			$	682.9
New Reportable Segment Structure:
	Asia/Latin America		$	280.9			$	239.9			$	193.1			$	219.0			$	211.5			$	201.4			$	179.7			$	811.6			$	656.3
	North America/Europe		31.8				72.2				53.2				90.7				84.7				68.9				64.1				308.4				347.5
	Corporate and Other		(63.9		)		(63.8		)		(63.1		)		(87.1		)		(92.5		)		(68.6		)		(97.7		)		(345.9		)		(320.9		)
Total			$	248.8			$	248.3			$	183.2			$	222.6			$	203.7			$	201.7			$	146.1			$	774.1			$	682.9

« First ‹ Previous 1 2 3 4 5 6 Next › Last »